Trial intelligence / Profile preview

Virgin Coconut Oil in Dyslipidemia

NCT03906539Phase 4Completed

Sponsor
AIIMS New Delhi
Start
May 2019
Primary completion
Nov 2021
Countries
1
01

Overview

Phase 4, randomised, double-blind trial (2 arms), sponsored by AIIMS New Delhi. Primary endpoint: Change in serum High Density Lipoprotein (HDL) at 8 weeks. Started May 2019; status: completed.

Beyond the preview

Go deeper on NCT03906539.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03906539.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call